MapLight Therapeutics, Inc. (NASDAQ:MPLT) Financings
Financings
| Raise | Date |
|---|---|
| Private placement of common stock and pre-funded warrants Announced: about US$150M · US$11.38 a share · Morgan Stanley +3 Dealers: Morgan Stanley, Jefferies, Leerink Partners, Stifel Use of proceeds: Advance ML-007C-MA, including the VISTA Phase 2 and ZEPHYR-2 Phase 3 studies, plus working capital and general corporate purposes | Aug 13, 2026 |
| Public offering of common stock Closed: US$17 a share · Morgan Stanley +3 Dealers: Morgan Stanley (co-lead), Jefferies (co-lead), Leerink Partners (co-lead), Stifel (co-lead) | Oct 29, 2025 |
| Private placement of common stock Closed: US$17 a share Buyers: Affiliates of Goldman Sachs & Co. LLC (476,707 shares of common stock, including certain investment funds managed by Goldman Sachs & Co. LLC) | Oct 29, 2025 |